Tech Company Financing Transactions

Amberstone Biosciences Funding Round

On 1/7/2022, Amberstone Biosciences landed $12 million in Series A funding from Co-win Healthcare Fund, Sinovation Ventures and Viva Ventures Biotech.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

23181 Verdugo Dr. 106
Laguna Hills, CA 92653
USA

Phone

Undisclosed

Website

www.amberstonebio.com

Email Address

[email protected]

Overview

With a bold vision to pioneer a new wave of therapeutic breakthroughs, our team of dedicated and passionate scientists and entrepreneurs strive to discover transformative therapeutic antibodies through innovative technologies and creative partnerships to benefit patients with unmet medical needs.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

George Wu

        

Browse more venture capital transactions:

Prev: 1/7/2022: Finexio venture capital transaction
Next: 1/7/2022: Eikon Therapeutics venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record tech company VC transactions. All VC database entries reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary